Patent
Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
William J. Kruper,Pollock Douglas K,Fordyce William A,Fazio Michael J,Muthiah N. Inbasekaran +4 more
Reads0
Chats0
TLDR
A group of functionalized polyamine chelants that form complexes with radioactive rhodium is described in this article, which can be attached to an antibody or antibody fragment and used for therapeutic or diagnostic purposes.Abstract:
A group of functionalized polyamine chelants that form complexes with radioactive rhodium are disclosed. The rhodium complexes can be attached to an antibody or antibody fragment and used for therapeutic or diagnostic purposes.read more
Citations
More filters
Patent
Albumin Fusion Proteins
TL;DR: The present invention encompasses albumin fusion proteins as discussed by the authors, as well as vectors containing these nucleic acids, host cells transformed with the nucleic acid vectors, and methods of making the fusion proteins of the invention.
Patent
Coating for Implantable Devices and a Method of Forming the Same
Syed F. A. Hossainy,Stephen D. Pacetti,Keith E. Fong,Vinayak D. Bhat,Deborra Sanders Millare,Judy A. Guruwaiya,Daryush Mirzaee,Evagenia Mandrusov +7 more
TL;DR: Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided in this article, including a method of forming the coatings, which can be used for the delivery of an active ingredient or a combination of active ingredients.
Patent
Variable surface area stent
TL;DR: A stent of variable surface area as determined by stent struts can be cut with struts of variable thickness to provide the variable stent surface area as mentioned in this paper, and a patterned distribution of therapeutic agent can be provided throughout the stent.
Patent
Antibodies that immunospecifically bind to trail receptors
Theodora W. Salcedo,Steven M. Ruben,Craig A. Rosen,Vivian R. Albert,Clarie Louise Dobson,Tristan Vaughan +5 more
TL;DR: In this paper, the authors present methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially cancer and other hyperproliferative disorders, comprising administering to an animal, preferably a human, an effective amount of one or more antibodies or fragments or variants thereof, or related molecules, that immunospecifically bind to TRAIL receptor TR7.
References
More filters
Patent
Macrocyclic bifunctional chelating agents
TL;DR: The linker-copper chelate conjugate as discussed by the authors was designed for use in diagnostic and therapeutic applications which involve Cu(II) localization via the systemic route, and is stable in human serum.
Patent
Chelating agents and method
TL;DR: In this article, a simple method for making EDTA, ED3A or DTPA analogs from amide derivatives of alpha amino acids is disclosed, which is useful as bifunctional chelating agents which may be attached to biological molecules.
Journal ArticleDOI
Catalysts for dihydrogen evolution from water based on rhodium complexes with polyamines
E. R. Savinova,Alexander I. Kokorin,A. P. Shepelin,A.V. Pashis,P.A. Zhdaan,Valentin N. Parmon +5 more
TL;DR: The structure of polymeric complexes of rhodium(III), synthesized from ethanolic solutions of RhCl3 and various polyamines and recently found to be rather efficient catalysts for dihydrogen evolution from water after some activation, is discussed in this article.
Journal ArticleDOI
Catalysts for dihydrogen evolution from water based on rhodium-polyamine complexes: Part II: The activity of catalysts and nature of their active components
E. R. Savinova,Dmitry I. Kochubey,M.A. Koslov,V.A. Chernov,S. V. Bogdanov,E.M. Moros,Vladimir I. Zaikovskii,A. P. Shepelin,Valentin N. Parmon +8 more
TL;DR: In this article, the catalysts based on Rh(III) complexes with amine polymers PEI and AN-221 are shown to be active and stable catalysts for dihydrogen evolution from water by such strong one-electron reductants as V 2+ (aq) and Cr 2+(aq).